"Antineoplastic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
| Descriptor ID |
D000970
|
| MeSH Number(s) |
D27.505.954.248
|
| Concept/Terms |
Antineoplastic Agents- Antineoplastic Agents
- Agents, Antineoplastic
- Antineoplastic Drugs
- Drugs, Antineoplastic
- Antineoplastics
- Chemotherapeutic Anticancer Drug
- Drug, Chemotherapeutic Anticancer
- Antitumor Drugs
- Drugs, Antitumor
- Cancer Chemotherapy Agents
- Agents, Cancer Chemotherapy
- Chemotherapy Agents, Cancer
- Cancer Chemotherapy Drugs
- Chemotherapy Drugs, Cancer
- Drugs, Cancer Chemotherapy
- Chemotherapeutic Anticancer Agents
- Agents, Chemotherapeutic Anticancer
- Anticancer Agents
- Agents, Anticancer
- Antitumor Agents
- Agents, Antitumor
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Agents".
This graph shows the total number of publications written about "Antineoplastic Agents" by people in this website by year, and whether "Antineoplastic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 15 | 1 | 16 |
| 1998 | 15 | 2 | 17 |
| 1999 | 11 | 2 | 13 |
| 2000 | 13 | 5 | 18 |
| 2001 | 9 | 4 | 13 |
| 2002 | 15 | 4 | 19 |
| 2003 | 18 | 5 | 23 |
| 2004 | 12 | 10 | 22 |
| 2005 | 29 | 8 | 37 |
| 2006 | 16 | 17 | 33 |
| 2007 | 15 | 22 | 37 |
| 2008 | 31 | 10 | 41 |
| 2009 | 24 | 22 | 46 |
| 2010 | 30 | 18 | 48 |
| 2011 | 37 | 19 | 56 |
| 2012 | 35 | 16 | 51 |
| 2013 | 42 | 22 | 64 |
| 2014 | 38 | 16 | 54 |
| 2015 | 50 | 32 | 82 |
| 2016 | 65 | 26 | 91 |
| 2017 | 46 | 18 | 64 |
| 2018 | 52 | 23 | 75 |
| 2019 | 50 | 18 | 68 |
| 2020 | 40 | 7 | 47 |
| 2021 | 54 | 16 | 70 |
| 2022 | 19 | 2 | 21 |
| 2023 | 25 | 3 | 28 |
| 2024 | 10 | 19 | 29 |
| 2025 | 41 | 9 | 50 |
| 2026 | 20 | 4 | 24 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Agents" by people in Profiles.
-
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. Blood. 2026 08 06; 148(6):751-766.
-
Development of a structurally distinct TopBP1 inhibitor that enhances PARP blockade and reverses osimertinib resistance. Sci Adv. 2026 Aug 07; 12(32):eaeg1996.
-
Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma. Mol Cancer Ther. 2026 Aug 04; 25(8):1342-1356.
-
Recurrent Hypoglycemia Following Asparaginase Therapy for Lymphoid Malignancies in Childhood: The Texas Children's Hospital Experience. Pediatr Blood Cancer. 2026 Sep; 73(9):e70457.
-
Toxicity from asparaginase during acute lymphoblastic leukemia induction: a report from the Children's Oncology Group. Blood Adv. 2026 07 28; 10(14):4923-4930.
-
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation. Clin Pharmacokinet. 2026 Sep; 65(9):1389-1403.
-
Time to Personalize Surveillance for Cancer Therapy-Related Cardiac Dysfunction in HER2-Targeted Therapy: One Size Does Not Fit All. Curr Heart Fail Rep. 2026 Jul 22; 23(1).
-
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy. Cancer Treat Rev. 2026 Sep; 149:103190.
-
The role of anti-M?llerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy. J Assist Reprod Genet. 2026 Jul; 43(7):1985-2001.
-
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. Circulation. 2026 Aug 04; 154(5):e188-e205.